PGF and atrial fibrillation: This led to four subcohorts (A–D) showing that AF from women after CMV transmission without prior HIG treatment contains higher levels of PlGF and its soluble receptor sFlt1 compared to non-transmitting women with or without HIG treatment, discordant to published data.